Literature DB >> 28324802

Pelvic exenteration case series: A single surgeon's experience at one institution in Trinidad and Tobago.

Ravi Maharaj1, Vandana Devika Sookdeo2, Maurice Fortuné3, Meenakshi Akhilesh4, Chalapathi Rao Adidam Venkata5, Wayne Mohammed6, Dave Harnanan7, Wayne A Warner8.   

Abstract

INTRODUCTION: Pelvic exenteration (PE) is an ultra-radical surgical procedure characterized by the en bloc resection of the pelvic organs.
METHODS: In this case series, we report retrospectively on four patients who underwent PE in Trinidad and Tobago from 2012 to 2016. One male patient had rectal cancer while one each of three women had cervical, colon, or rectal cancer.
RESULTS: Early postoperative complications (≤30days) occurred in all patients, while late complications (>30days) occurred in one patient (Grade 1 - Clavien-Dindo classification). Disease recurrence occurred in 50% of patients, and the median overall survival was 8 months (range, 4-15 months). DISCUSSION: There are many inherent challenges to conducting such major procedures in developing countries, including inadequate blood product supplies, intensive care unit beds, and pre- and post-operative support services. With increased surgical capacity and support infrastructure, hospitals in these regions would be equipped to perform PEs with better outcomes.
CONCLUSION: This case series adds to existing data on the feasibility of performing PE in developing countries. We demonstrate that PE can be performed without major postoperative complications in a resource-limited hospital. To the best of our knowledge, this is the first case series that describes PE in the Caribbean.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cancer; Case series; Pelvic exenteration; Retrospective single institution review; Trinidad and Tobago

Year:  2017        PMID: 28324802      PMCID: PMC5358951          DOI: 10.1016/j.ijscr.2017.03.006

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Pelvic exenteration (PE) is an ultra-radical surgical procedure that was initially performed at the Ellis Fischel Cancer Center and later described by Brunschwig in 1948 [1], [2]. It is characterized by the en bloc extirpation of the internal reproductive organs, pelvic peritoneum, regional lymph nodes, anal canal, distal colon and rectum, bladder, and inferior ureters. Pelvic exenteration is indicated in cases of persistent or recurrent malignancy in the pelvic region post chemoradiation, tumor confinement to the central pelvic region, and possible resectability to R0 margins. Public exenteration is rarely performed in developing countries. A literature search in PubMed/Medline and EMBASE databases using the search topics “pelvic exenteration” and “Africa” and/or “developing countries” and/or “Latin America” and/or “South America” and/or “Central America” and/or “low income countries” and/or “Caribbean” retrieved 16 citations. To the best of our knowledge, this is the first case series that describes PEs in the Caribbean. We report on all PEs carried out at the Eric Williams Medical Sciences Complex (EWMSC), Champ Fleurs, Trinidad and Tobago as performed by a single surgeon. This case report was prepared according to the Process Guidelines, which provide a framework for reporting surgical case series [3].

Materials and methods

This case series involved retrospective review of PE cases performed at a public tertiary teaching hospital in Trinidad and Tobago from 2012 to 2016 by a single general surgeon with subspecialty training in surgical oncology.

Results

Patient demographics, family history of cancer, behavioral characteristics, preoperative indications, and pre- and postoperative complications are described in Table 1, Table 2, and Table 3 , respectively. Preoperative computed tomography (CT) images are shown in Fig. 1. Elements of the operative procedure have been reported previously [4] and will be briefly reviewed here. In general, there are three types of PEs: anterior exenteration, posterior exenteration, and total or radical exenteration. Each type is divided into two phases: the exenterative phase, which aims to achieve clear pathologic margins, and the reconstructive phase, which aims to optimize functional outcomes by creating an ileal conduit, reinforcing the pelvic floor, and restoring bowel continuity. In each case, the patient was placed in the lithotomy position and the abdomen and perineum were cleaned and draped. Following a midline incision, the abdomen was opened in layers. A thorough exploration of the peritoneal cavity and retroperitoneal spaces was executed, including opening the retroperitoneal spaces and developing them all the way to the pelvic floor. Next, the sigmoid colon and/or ureters were completely mobilized and divided. Then, the organs to be removed were mobilized. For anterior exenterations, these can potentially include the bladder, vagina, uterus or prostate/seminal vesicles, cervix, and adnexae. For posterior exenterations, these can potentially include the rectosigmoid colon, vagina, uterus or prostate/seminal vesicles, cervix, and adnexae. Finally, total or radical exenterations removed all of the listed tissues. The appropriate organs were mobilized en-bloc by utilizing sharp and blunt dissection, clamp–cut–tie sequences, and/or electrosurgical devices to address the relevant vascular supplies and suspensory attachments. After that, an elliptical perineal incision was made and infralevator resection of the external genitalia and/or anus was undertaken as indicated by disease extent. Individualized urinary diversion and vaginal and/or perineal reconstruction were then performed. To complete the procedure, a Jackson-Pratt closed suction drain was sutured in to the perineum. Selected intraoperative and specimen images are shown in Fig. 2.
Table 1

Patient demographics.

Patient no.GenderAncestryAge (years)BMIFamily history of cancerAlcohol/smoking history
1FemaleIndian4513.7Father: Throat CA, Breast CAMother: Breast CANone
2FemaleAfrican5231.6NoneNone
3MaleIndian5116.9NoneSmoker: 80 pack years Alcohol: Heavy
4FemaleIndian6515.4NoneNone

BMI, body mass index; CA, cancer.

Table 2

Preoperative indications.

Patient no.Preoperative diagnosisPreoperative co-morbiditiesPreoperative complicationsPreoperative surgical historynCRT
1Uterine leiomyomata, locally advanced stage 4 cervical CA (left side ureter and rectovaginal fistula invasion)HypertensionPelvic and rectal bleeding, constipation, constant pain (lower abdomen, lower back, limbs), bilateral hand swelling, persistent anemia, obstruction of left nephrostomy tube due to atrophic left kidney, scoliosis, pelvic passage of urine and stoolMyomectomy, partial hysterectomy, radical total abdominal hysterectomy with bilateral salpingo-oophorectomy, left and right nephrostomy6 weeks Taxol and Gemcitabine, 6 weeks radiation



2Colon CA eventually invading the bladderNoneSevere constipation, abdominal pain, infection post colonoscopyPartial colectomy1 week chemotherapy, 1 week radiation



3Rectal CA eventually invading the bladder, prostate, and right hepatic lobeAnemiaChange in bowel movements associated with perineal pain, tenesmus, melena, constipation, post radiation difficulty urinatingNone6 cycles Xelox and Avastin, 20 fractions radiation



4Rectal CA stage IV with vaginal invasion, rectovaginal fistulaType 2 diabetes mellitusVaginal bleeding, constipation, anemiaHysterectomy and ileostomy4 cycles chemotherapy, 1 cycle radiation

nCRT, neoadjuvant chemoradiotherapy.

Table 3

Pre- and postoperative complications, according to Clavien-Dindo classification.

Patient numberType of postoperative complication A (<30 days after surgery):0 = No complication1 = Infection2 = Fistula3 = Bleeding/hematoma4 = DGE/N&V5 = Cardiopulmonary6 = Liver insufficiency7 = Neurologic8 = Pain9 = Allergy10 = Pancreatitis11 = OtherDescription of complication AGrade of complication A1 = Grade I2 = Grade II3 = Grade IIIa4 = Grade IIIb5 = Grade IVa6 = Grade Ivb7 = Grade VType of postoperative complication B (>30 days after surgery):0 = No complication1 = Infection2 = Fistula3 = Bleeding/hematoma4 = DGE/N&V5 = Cardiopulmonary6 = Liver insufficiency7 = Neurologic8 = Pain9 = Allergy10 = Pancreatitis11 = OtherDescription of complication BGrade of complication B1 = Grade I2 = Grade II3 = Grade IIIa4 = Grade IIIb5 = Grade IVa6 = Grade IVb7 = Grade VGrade of highest complication1 = Grade I2 = Grade II3 = Grade IIIa4 = Grade IIIb5 = Grade IVa6 = Grade IVb7 = Grade VOverall total number of complications
11UTI11Wound infection115
18Pain in left leg from stenosis of left common and external iliac arteries1
111Wound dehiscence4
111Decrease in appetite1
211Wound dehiscence402
211Decrease in appetite1
38Pain at wound site101
41Wound infection14
48Pain at wound site10
411Stoma ischemia4
411Decrease in appetite1

DGE/N&V, delayed gastric emptying/nausea and vomiting; UTI, urinary tract infection.

Fig. 1

Pre- and postoperative CT images. Red arrows indicate the regions invaded by the tumors. A1) Patient 1 preoperative, A2) Patient 1 postoperative, B1) Patient 2 preoperative, B2) Patient 2 postoperative, C1) Patient 3 preoperative, C2) Patient 3 postoperative, D1) Patient 4 preoperative, D2) Patient 4 postoperative.

Fig. 2

Intraoperative images. A) Patient 2, completed perineal dissection including urethra, vagina, and anus; B) Patient 2, perineum closed, suction drains placed; C) Patient 3, specimen following pelvic exenteration in a male patient, including rectum, anus, prostate, and bladder.

All four patients had a PE with colostomy, ileal conduit, urinary diversion, and R0 margins. Patients 1, 2, and 4 were N0, while patient 3 was positive for lymph node metastasis. The postoperative complications graded by the Clavien-Dindo [5] classification and summarized in Table 3 show that none of the patients had major complications (>grade 3) in the late postoperative period. The long term oncologic outcomes are summarized in Table 4. With a median follow-up of eight months (range 4–15 months), two patients remain alive with no sign of recurrence.
Table 4

Intraoperative and postoperative features and outcomes.

Patient no.Date of PERadicalReconstruction detailsOperative findingsOperative time, minBlood loss, mlSpecimens collectedPathological stagePRMLength of postoperative hospitalizationEvaluation 5 months post-surgerypCRTOutcome
12016YesPE, colostomy, ileal conduit, urinary diversionAdhesions, frozen pelvis with partial radiation changes, rectovaginal fistula, gross pelvic tumor growth720400Iliac lymph node, colon proximal resection with vascular pedicle, anal verge, rectum with fistula, bladder with urethra, vulva, vaginapT4N0M0NegativeICU (3 days), surgical ward (8 days), re-hospitalization (54 days)UnavailableNoneAlive



22014YesPE, colostomy, ileal conduit, urinary diversionFumigating necrotic mass located 5 cm from rectal surgical resection margin, extending into urinary bladder and vaginal cuff6004000Section from rectal end of surgical resection margin; 2nd surgical resection margin, mass in bowel, ureters, urinary bladder, vaginal wallpT3 b/c pNX pM1.M1Negative90 daysRelief of constipation and pain, psychological relief, hopeful for extended life. Unable to continue job but able to travel and live independently.YesPassed away 369 days post PE of tumor recurrence



32012YesAnterior pelvic exenteration, ileal conduit, urinary diversionLarge rectal tumor invading bladder and prostate; nodules palpated in liver segments 3,6 76012000Left ureter, right ureter, distal sigmoid colon, rectum, anus, bladder, prostatepT4BNegative9 daysReturned to job and preoperative QoLYesPassed away 470 days post PE of tumor recurrence



42016YesPosterior exenteration, colostomy, ileal conduit, urinary diversion, double-J stent placementPelvic visceral peritoneum, abdominal wall, ileum, liver adhesions451200Anus, sphincter complex, lower rectum, posterior vaginal wall, caecum, ascending colon, distal ileumpT4B pNX pM0NegativeHDU (14 days), surgical ward (35 days)UnavailableNoneAlive

HDU, high dependency unit; ICU, intensive care unit; pCRT, post discharge chemoradiotherapy; PRM, pathological resection margin; QoL, quality of life.

Discussion

Pelvic exenteration is the only potentially curative intervention for patients with advanced and recurrent pelvic cancers. In this case series, we report on four patients who underwent PEs in Trinidad and Tobago as performed by a single surgeon. Despite its status as a high income country [6], there are challenges to performing this type of operation in Trinidad and Tobago given the absence of a surgical team dedicated to such procedures. In this case series, a general surgeon with subspecialty training in surgical oncology led the operative teams. This surgeon performs a wide range of procedures, ranging from general cases to intra-abdominal and breast cancer surgeries. In contrast, high volume specialty hospitals typically employ a two-team approach to PEs, with one team conducting the exenterative phase of the PE and a second team performing the reconstructive phase. When PEs are conducted by such surgical teams in hospitals with specialty expertise, the operative 30-day mortality drops from 3.7 to 1.5% [7]. Other challenges to conducting these radical surgeries in developing countries include limited availability of blood products and intensive care unit beds. In these settings, pre- and postoperative support services such as physiotherapy, nutrition, and psychology are often stretched thin. Additionally, PEs take more than 10 h on average, which increases the waiting time for other surgical cases. Remarkably in this case series, there were no peri- or postoperative mortalities during the first 12 months following surgery. Additionally, only three and zero patients suffered major complications (grade 3 or above) in the early and late postoperative periods, respectively. In this series, only one patient was positive for lymph node metastasis. The literature is inconclusive on the impact of tumor-involved lymph nodes. Some case series have reported that lymph node involvement was not predictive of survival [8], [9], while others have reported that positive lymph nodes are associated with an increased risk of recurrence and should be a contraindication for PEs [10], [11]. The literature is more definitive in relation to tumor-involved margins as a poor prognostic indicator. In our series, all of the patients had R0 resections. Given the poor prognosis associated with positive surgical margins after PE and the significant morbidity, even mortality, seen in conjunction with these procedures, it is generally accepted that fixation of the tumor to the pelvic side wall is a contraindication to PE [8]. The poor survival reported by many case series points to the need for histopathologic review, improved patient surveillance, and personalized chemoradiotherapy algorithms [8], [12]. The optimal imaging modality when considering PE is positron emission tomography/computed tomography (PET/CT). While magnetic resonance imaging and stand-alone CT have demonstrated utility in mapping the pelvic tumor burden, PET/CT’s ability to identify recurrent disease in patients with gynecologic malignancies and distinguish persistent or recurrent tumors from those induced by post–PE radiotherapy renders it superior [13]. Currently, PET imaging units are not available in Trinidad and Tobago or most developing countries, limiting a surgical teams’ ability to assess tumor characteristics and determine patients’ eligibility for PE. Accurate evaluation is critical for optimal patient selection. Numerous studies have posited that careful selection of PE candidates may increase 5-year survival rates and patients’ quality of life [14], [15], [16]. Given the high risk of operative-associated morbidity, special attention to a holistic approach to postoperative management should be considered in settings like Trinidad and Tobago where many patients self-identify as being religious. It has been reported that enhanced recovery from surgery and better pain management is among the benefits enjoyed by patients receiving postoperative compassionate support that serves the whole person: physical, emotional, social, and spiritual [17]. Furthermore, the Joint Commission on Accreditation of Healthcare Organizations suggests that pastoral care and other spiritual services are an integral part of health care and that hospitals should provide pastoral care and other spiritual services for patients who request them as part of the recovery process [18]. Many patients struggle with psychological, social, and sexual adjustments after undergoing PE [19]. To ameliorate this impact, hospitals should consider offering the personalized service of a “care coach”. Ideally, this position would be held by a nurse with specialties in psychiatry and oncology. Responsibilities could include: inpatient and outpatient patient and family counselling and education, proper stoma bag care, ensuring adequate home preparations prior to discharge, scheduling follow-up clinic visits, and arranging social work appointments. Additionally, patient navigators should be available to support the timely movement of PE patients through the health care system [20]. Integrating these services into a multi-disciplinary approach to PE clinical case management should contribute to lowered morbidity and improved survival rates.

Conclusion

While the number of cases in our series limits survival statistics assessment, we demonstrated that PEs can be performed safely in a developing country with minimal complications. We believe that increased surgical capacity, a multidisciplinary surgical board, rigorous patient selection, support services, thorough post-operative management and overall technical capacity are necessary if these operations are to become routine options in developing countries.

Conflict of interest

None.

Sources of funding

WAW was supported by Washington University School of Medicine, GSAS/CGFP Fund94028C.

Ethical approval

Ethical approval was not required since patient is de-identified.

Consent

Consent provided.

Authors contribution

The operations were carried out by Ravi Maharaj and Dave Harnanan. Pathology services were performed by Meenakshi Akhilesh, A.V.C. Rao, and Wayne Mohammed. The radiological imaging studies were reported and managed by Maurice Fortuné. Vandana Sookdeo assisted in critical discussions. Wayne A. Warner wrote the manuscript. All authors approved the final version.

Registration of research studies

N/A.

Guarantor

Ravi Maharaj. Vandana Devika Sookdeo. Maurice Fortuné. Meenakshi Akhilesh. A.V.C. Rao. Wayne Mohammed. Dave Harnanan. Wayne A. Warner.
  18 in total

1.  Complete Excision of Pelvic Viscera in the Male for Advanced Carcinoma of the Sigmoid Invading the Urinary Bladder.

Authors:  A Brunschwig
Journal:  Ann Surg       Date:  1949-04       Impact factor: 12.969

2.  Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy.

Authors:  A BRUNSCHWIG
Journal:  Cancer       Date:  1948-07       Impact factor: 6.860

3.  The origin, evolution, and principles of patient navigation.

Authors:  Harold P Freeman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10       Impact factor: 4.254

4.  Indications for primary and secondary exenterations in patients with cervical cancer.

Authors:  Simone Marnitz; Christhardt Köhler; Marianne Müller; Katja Behrens; Kati Hasenbein; Achim Schneider
Journal:  Gynecol Oncol       Date:  2006-08-04       Impact factor: 5.482

5.  Pelvic exenteration for carcinoma of the uterine cervix. A 15-year experience.

Authors:  A S Ketcham; P J Deckers; E V Sugarbaker; R C Hoye; L B Thomas; R R Smith
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

6.  Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981).

Authors:  R A Lawhead; D G Clark; D H Smith; V K Pierce; J L Lewis
Journal:  Gynecol Oncol       Date:  1989-06       Impact factor: 5.482

7.  Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.

Authors:  H M Shingleton; S J Soong; M S Gelder; K D Hatch; V V Baker; J M Austin
Journal:  Obstet Gynecol       Date:  1989-06       Impact factor: 7.661

8.  Psychosexual adjustment following pelvic exenteration.

Authors:  B L Andersen; N F Hacker
Journal:  Obstet Gynecol       Date:  1983-03       Impact factor: 7.661

9.  Impact of hospital volume on operative mortality for major cancer surgery.

Authors:  C B Begg; L D Cramer; W J Hoskins; M F Brennan
Journal:  JAMA       Date:  1998-11-25       Impact factor: 56.272

10.  Preferred reporting of case series in surgery; the PROCESS guidelines.

Authors:  Riaz A Agha; Alexander J Fowler; Shivanchan Rajmohan; Ishani Barai; Dennis P Orgill
Journal:  Int J Surg       Date:  2016-10-19       Impact factor: 6.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.